HLA-G in B-chronic lymphocytic leukaemia:: Clinical relevance and functional implications

被引:27
作者
Rebmann, Vera [1 ]
Nueckel, Holger [2 ]
Duehrsen, Ulrich [2 ]
Grosse-Wilde, Hans [1 ]
机构
[1] Univ Klinikum Essen, Inst Immunol, D-45122 Essen, Germany
[2] Univ Klinikum Essen, Zentrum Innere Med, Abt Hamatol, Essen, Germany
关键词
HLA-G; sHLA-G; B-CLL; immune escape mechanism;
D O I
10.1016/j.semcancer.2007.06.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HLA-G appears to be involved in regulatory functions counteracting the cellular immune response of T and NK cells by several pathways. We here summarize the HLA-G expression patterns in leukaemia with emphasis on the clinical relevance of this expression for disease progression. Especially in patients with B-chronic lymphocytic leukaemia (B-CLL) the HLA-G expression on B-CLL cells was strongly associated with a reduced treatment-free survival. The corresponding immunological parameters point to a broad immunosuppression in these patients. Thus, HLA-G seems to contribute to the impaired immune response in B-CLL supporting disease progression. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:430 / 435
页数:6
相关论文
共 58 条
  • [1] Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia
    Amiot, L
    Onno, M
    Drenou, B
    leMarchand, B
    Lamy, T
    Semana, G
    Fauchet, R
    [J]. EUROPEAN JOURNAL OF IMMUNOGENETICS, 1996, 23 (04): : 311 - 320
  • [2] HLA-G and lymphoproliferative disorders
    Amiot, L
    Le Friec, G
    Sebti, Y
    Drénou, B
    Pangault, C
    Guilloux, V
    Leleu, X
    Bernard, M
    Facon, T
    Fauchet, R
    [J]. SEMINARS IN CANCER BIOLOGY, 2003, 13 (05) : 379 - 385
  • [3] HLA-G class I gene expression in normal and malignant hematopoietic cells
    Amiot, L
    Onno, M
    Drénou, B
    Monvoisin, C
    Fauchet, R
    [J]. HUMAN IMMUNOLOGY, 1998, 59 (08) : 524 - 528
  • [4] HLA-G transcription studies during the different stages of normal and malignant hematopoiesis (vol 47, pg 408, 1996).
    Amiot, L
    Onno, M
    Renard, I
    Drenou, B
    Guillaudeux, T
    LeBouteiller, P
    Fauchet, R
    [J]. TISSUE ANTIGENS, 1996, 48 (05): : 608 - 614
  • [5] APPS R, 2007, EUR J IMMUNOL
  • [6] HLA-G and NK receptor are expressed in psoriatic skin - A possible pathway for regulating infiltrating T cells?
    Aractingi, S
    Briand, N
    Le Danff, C
    Viguier, M
    Bachelez, H
    Michel, L
    Dubertret, L
    Carosella, ED
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) : 71 - 77
  • [7] HLA-G polymorphism and evolution
    Arnaiz-Villena, A.
    Martinez-Laso, J.
    Serrano-Vela, J. I.
    Reguera, R.
    Moscoso, J.
    [J]. TISSUE ANTIGENS, 2007, 69 : 156 - 159
  • [8] Disulfide bond-mediated dimerization of HLA-G on the cell surface
    Boyson, JE
    Erskine, R
    Whitman, MC
    Chiu, M
    Lau, JM
    Koopman, LA
    Valter, MM
    Angelisova, P
    Horejsi, V
    Strominger, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) : 16180 - 16185
  • [9] CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: Stimulation of allogeneic versus autologous T cells generates different types of effector cells
    Buhmann, R
    Nolte, A
    Westhaus, D
    Emmerich, B
    Hallek, M
    [J]. BLOOD, 1999, 93 (06) : 1992 - 2002
  • [10] Bukur J, 2003, CANCER RES, V63, P4107